Skip to content
TrialScanner

NCT05165485

Phase 4 COPD and Suboptimal Inspiratory Flow Rate

Phase 4CompletedTBPHLeadVTRSCollaborator

Registry record

Lead sponsor
Theravance Biopharma
Conditions
Chronic Obstructive Pulmonary Disease
Primary completion
Nov 13, 2023Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT05165485 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT05165485: Phase 4 COPD and Suboptimal... | TrialScanner